ライフサイエンスコーパス: withdraw

1 at 1 year after HSCT (one patient died, one withdrew).

2 No patients refused participation or withdrew.

3 than 9 months, even after all treatment was withdrawn.

4 d at the end of life or when life support is withdrawn.

5 021), and deteriorated when triheptanoin was withdrawn.

6 Patients only have relief when opioids are withdrawn.

7 ); however, virus rebounds soon after ART is withdrawn.

8 y to have exacerbations if ICS treatment was withdrawn.

9 ss and bacillary growth resumed when KGF was withdrawn.

10 uroblasts exit cell cycle when nutrients are withdrawn.

11 uent on the aryl group becomes more electron-withdrawing.

12 ith the 1,5-triazole being the most electron-withdrawing.

13 lock, which is end capped by strong electron-withdrawing 2-(5,6-difluoro-3-oxo-2,3-dihydro-1H-inden-1

14 to good yields for arenes carrying electron-withdrawing (50-85%) or weakly electron-donating groups

15 Hemorrhagic shock was induced in rats by withdrawing 60% of the blood volume and maintaining a hy

16 sally believed), or because they osmotically withdraw a large fraction of intracellular water prior t

17 The increase in electron-withdrawing ability of C(1)-substituents facilitates the

18 synthetic results suggest that high electron-withdrawing ability, which has traditionally limited rea

19 e of aryl rings, even those lacking electron-withdrawing activating groups, and provides a method for

20 r cyclopropanes with other types of electron-withdrawing activating groups.

21 tients (50%) had extracorporeal life support withdrawn after 6.7 +/- 3.6 days and were discharged aft

22 Two gluten-intolerant subjects were withdrawn after microchallenge.

23 tners will likely be drawn upon when bOPV is withdrawn after polio eradication but also could be rele

24 y be drawn upon when all OPVs are completely withdrawn after polio eradication, but also may offer a

25 Five infants had consent withdrawn after randomisation, thus 650 were analysed in

26 alth department to have their child's sample withdrawn after testing: 3 in the NBS + DBS group and 2

27 One participant from each group withdrew after consent, before intervention, leaving an

28 Two patients withdrew after day 0.

29 ne participant in VRC 319 and two in VRC 320 withdrew after one dose of vaccine, but were included in

30 rcurrent illness after the first visit and 1 withdrew after the second visit.

31 um salts bearing electron-donating, electron-withdrawing, alkyl, aryl, halogen, and haloalkyl substit

32 distinct from those of more common electron-withdrawing amide and sulfonamide units.

33 ) BF4(-) complexes substituted with electron withdrawing and donating functionalities in the para-pos

34 opentadiene rings on ferrocene with electron withdrawing and donating substituents, thus providing an

35 henyltellurophene compounds bearing electron-withdrawing and electron-donating substituents synthesiz

36 d after isovolaemic haemodilution (10% of BV withdrawn and replaced with an equal volume of 5% human

37 and have different sites from which blood is withdrawn and returned to the body.

38 Two patients withdrew and 5 required IL-2 dose reductions due to side

39 nalysis, which included two participants who withdrew and three who were lost to follow-up from the A

40 ring (whether electron donating or electron withdrawing) and can be extended to heteroaromatic analo

41 ituations in which antiangiogenic agents are withdrawn, and dual targeting of FAK and VEGF could have

42 he alkyne units, including electron-donating/withdrawing aryl groups, silyl-protected alkynyl groups,

43 This paper has been withdrawn as the authors did not fully consult with thei

44 t course tacrolimus (FK-506) monotherapy was withdrawn at postoperative day 21.

45 The influence of the electron-withdrawing azide group on the reduction of O-(1-acyloxy

46 anomeric charge development by the electron-withdrawing azide.

47 nt; two in the active observation group were withdrawn because they became ineligible after allocatio

48 ll tolerated over 4 years; 4 (2.5%) patients withdrew because of adverse events that were considered

49 Four withdrew because of adverse events, two each in the plac

50 Forty-one patients (14%) withdrew because of adverse events.

51 to group randomization, and no participants withdrew because of an adverse event.

52 group and four patients in the placebo group withdrew because of asthma exacerbations.

53 No participants withdrew because of side effects.

54 0 mg, 30 mg, and 60 mg groups, respectively) withdrew because of treatment-emergent adverse events co

55 vers declined consent, and two children were withdrawn before transfusion.

56 Six patients withdrew before the end of the study because of taste di

57 ent before the first post-baseline scan, two withdrew before the first post-baseline scan, and one ha

58 One patient in group A withdrew before treatment.

59 that more reactive nucleophiles and electron-withdrawing benzoyl groups on the donor favor the format

60 CM reporter via a self-eliminating, electron-withdrawing benzyl alcohol-carbamate linker offers a pro

61 ROAMP catalysts featuring electron-withdrawing benzylidynes not only selectively increase t

62 Additionally, in 11 patients we withdrew beta-blockers and diuretics and used phenylephr

63 SF5 functionality is also strongly electron-withdrawing but at the same time highly lipophilic.

64 e long-term follow-up were those who had not withdrawn by the 12 month follow-up and had given their

65 This article was withdrawn by the authors before final publication on Dec

66 This article has been withdrawn by the authors.

67 This article has been withdrawn by the authors.

68 omocoupling accelerated by the more electron-withdrawing CF3 substituent.

69 destabilizing the (1)p* state by an electron-withdrawing CN substituent at the ortho or para position

70 s emulates in a controlled manner the proton-withdrawing conditions of polycrystalline films, where e

71 SVR12 did not complete treatment because of withdrawing consent after receiving 1 dose of study drug

72 One patient withdrew consent (before the administration of artefenom

73 p 1 was not vaccinated because their parents withdrew consent after enrolment and randomisation, so 9

74 The remaining patient withdrew consent after in cycle 1 and attained a complet

75 Two participants allocated placebo withdrew consent after randomisation; thus, a total of 5

76 roup and 22 patients in the ipilimumab group withdrew consent and did not receive treatment.

77 48 weeks of treatment; two discontinued (one withdrew consent at week 8, one was lost to follow-up at

78 One patient (in the FST group) withdrew consent before drug administration and was excl

79 re available for analysis because 3 patients withdrew consent before scanning.

80 A total of 152 women withdrew consent during the trial, and 4 were lost to fo

81 A total of 50 women withdrew consent during the trial, which left 202 women

82 Two women withdrew consent for use of their data in the analysis.

83 ts (median age, 57 years; 18 [24%] women), 2 withdrew consent later and 1 was found to have been rand

84 Ten participants withdrew consent or discontinued prematurely, 6 owing to

85 One patient assigned to sequence 2 withdrew consent prior to receiving randomised therapy.

86 Three patients withdrew consent prior to starting the first cycle of ad

87 nt: 66 to EBUS-TBNA and 67 to CDS (one later withdrew consent).

88 t metastases at the time of randomization; 2 withdrew consent).

89 Of the 5 patients who did not achieve SVR, 1 withdrew consent, 2 had confirmed virologic relapse or b

90 Fifty-two participants withdrew consent, and 1,387 participated in the study.

91 One patient withdrew consent, leaving 3036 patients included in the

92 Seven women were lost to follow-up, six withdrew consent, one died, and two relocated.

93 cumentation of informed consent, immediately withdrew consent, or randomly assigned to intervention g

94 A total of 3 women withdrew consent, so 289 women in the intervention group

95 ue to prior enrollment in this trial and one withdrew consent.

96 ts relapsed, 2 were lost to follow-up, and 1 withdrew consent.

97 Patients reported more withdrawn/depressed behavior (z score = -0.47 [0.54]; p

98 comfort care, 31 (38%) had care withheld or withdrawn despite available medical options, 15 (19%) ha

99 luded from the primary analysis patients who withdrew, died, or did not attend the 32 week assessment

100 Remarkably, electron withdrawing/donating aroyl units including heterocyclic

101 vity correlating to the strength of electron-withdrawing/-donating groups on the ring of each substra

102 rces for patented drugs, their side effects, withdrawn drugs, and potential drug targets.

103 en in the interval appendicectomy group were withdrawn due to withdrawal of consent; two in the activ

104 ipants assigned to treatment minus those who withdrew due to a non-treatment-related cause.

105 No participant withdrew due to adverse effects.

106 No patients withdrew due to adverse events.

107 3.1%) patients, whereas two patients (15.4%) withdrew due to subjective side-effects at first dose.

108 One participant withdrew during the first closed-loop period because of

109 8 participants, 85% completed follow-up, 11% withdrew early, and 4% were lost to follow-up; 19% disco

110 ene and the acceptor unit IC due to electron-withdrawing effect of F, and finally adjust energy level

111 the chlorine atom on increasing the electron withdrawing effect of the R substituent.

112 1,5-triazole group exerts a strong electron-withdrawing effect on carbocations that is not offset by

113 al-stabilizing energies rather than electron-withdrawing effects as the dominating feature of the HDD

114 reaction tolerates a wide range of electron-withdrawing, electron-neutral, and electron-donating sub

115 and 1,1-dicyanomethylene-3-indanone electron-withdrawing end groups.

116 le chemical modifications on strong electron-withdrawing end-groups.

117 III trials (and preclinical work) and not be withdrawn even later from the marketplace due to cardiot

118 terventions withdrawn, with vasoactive drugs withdrawn first followed by gradual withdrawal of mechan

119 Despite the presence of the highly electron-withdrawing fluorinated substituent, cyclic alpha-triflu

120 ster from complexes containing less electron-withdrawing fluoroenolate groups and longer Pd-C(enolate

121 than from complexes containing more electron-withdrawing fluoroenolate groups and shorter Pd-C(enolat

122 uced by 50% for 3 months and then completely withdrawn for 3 months.

123 No patients were withdrawn for adverse effects.

124 of patients with a CIDP relapse or who were withdrawn for any other reason during 24 weeks of treatm

125 h were retired (due to old age) and 17% were withdrawn for behavioural issues.

126 g patients who declined intervention or were withdrawn for protocol violations.

127 s, several highly prescribed drugs have been withdrawn for their ability to cause such proarrhythmia.

128 ch to conducting research on individuals who withdraw from living kidney donor evaluation.

129 w an outer membrane-anchored LpoA can either withdraw from or extend toward the inner membrane-bound

130 Yet, many patients withdraw from SSRI therapy due to sexual side effects (e

131 Mammalian cardiomyocytes permanently withdraw from the cell cycle shortly after birth but can

132 stence of response in subjects continuing or withdrawing from long-term omalizumab treatment.

133 in 109 participants, resulting in 8 patients withdrawing from the study.

134 cturally distinct BACE1 inhibitors have been withdrawn from development after inducing ocular toxicit

135 w months after its approval, natalizumab was withdrawn from the market because of an unanticipated li

136 unts for a substantial number of drugs being withdrawn from the market.

137 46]) on high-dose SCIg had a relapse or were withdrawn from the study for other reasons (p=0.0007).

138 Patients were withdrawn from the study on development of grade 2 or hi

139 evidence of disease progression on MRI, had withdrawn from the study to undergo allogeneic stem-cell

140 y centre and resolved, and the patients were withdrawn from the study.

141 Nitarsone was withdrawn from the U.S. market in 2015, but its use in o

142 Responders were withdrawn from treatment (for up to 36 weeks) and re-tre

143 mofetil than on cyclophosphamide prematurely withdrew from study drug (20 vs 32) or met prespecified

144 More patients in the mFOLFOX6 arm withdrew from study due to adverse events than in the FU

145 er from the standard treatment group and ten withdrew from study, leaving only six patients at 5 year

146 Two participants withdrew from the AQ-13 group after parasite clearance a

147 ower baseline spending, and the 13 ACOs that withdrew from the Pioneer program after 2012 and the 19

148 s and those without, as well as in ACOs that withdrew from the program and those that did not.

149 No children withdrew from the study because of adverse effects.

150 early recurrence of about 2%; 6% of patients withdrew from the study because of protocol-specified ad

151 s: three were not properly randomised, three withdrew from the study, and one was lost to follow-up.

152 patient was non-adherent to study drugs and withdrew from the study, but was included in the intenti

153 e patients, 6 were excluded, including 1 who withdrew from the study.

154 One participant withdrew from the trial 240 days after enrolment and 12

155 12 patients withdrew from the trial: seven from the PTNS group and f

156 ing their chemical structures using electron-withdrawing functional groups.

157 In the absence of an activating electron-withdrawing group as part of the Michael acceptor, a hig

158 rescence quantum yield, whereas the electron withdrawing group at the meso position of BODIPY red shi

159 th the higher dipole moment and the electron-withdrawing group in the equatorial phenyl ring and/or a

160 The effects of an electron-withdrawing group on the organic chemistry of an eta(2)-

161 een reported in which an additional electron-withdrawing group was added at the alpha-carbon of a Mic

162 ining an alkenyl moiety and diverse electron-withdrawing group(s) at the adjacent positions, into sub

163 n nitrogen nucleophiles bearing one electron-withdrawing group, and proceeds under mild reaction cond

164 intermediates 3 contain a strongly electron-withdrawing group, such as C(4)-Cl or C(5)-NO2, they rea

165 le electrostatic interactions, with electron-withdrawing groups (EWG) on the sp(2) system leading to

166 gma), which has positive values for electron-withdrawing groups (EWGs) and negative values for electr

167 -tuned through the incorporation of electron-withdrawing groups (EWGs) like nitro and cyano at the ph

168 lpyridines containing electron-donating and -withdrawing groups appear to be well-tolerated by this t

169 f substrates which include reactive electron-withdrawing groups are well tolerated to form 2-substitu

170 Lastly, hydrophobic electron-withdrawing groups at several positions in the adenine c

171 y is tolerant to electron-donor and electron-withdrawing groups at the substrates and the desired pro

172 In addition, the effect of electron withdrawing groups bonded to a nitrogen atom, namely the

173 Stronger electron-withdrawing groups display more significant bathochromic

174 s functionalized with destabilizing electron-withdrawing groups like halides, carboxyesters, and nitr

175 Interestingly electron-withdrawing groups on O-6 or on C-1 of the acceptor disp

176 ly electron-releasing or moderately electron-withdrawing groups on the aldehyde reactant.

177 her tuned by employing electron-donating or -withdrawing groups on the azulene ring.

178 e of beta-sulfonyl enamines without electron-withdrawing groups on the nitrogen atom.

179 ubstitution with electron-donating groups or withdrawing groups or with increased conjugation.

180 epared installing the electron-donating and -withdrawing groups through a multicomponent reaction.

181 and the observed effect of proximal electron-withdrawing groups upon the degradation rates.

182 cient when using substrates bearing electron-withdrawing groups, and allowed for the preparation of a

183 y aryl halides bearing an electron donor and withdrawing groups, as well as by heterocyclic halides i

184 ble with a variety of electron-donating and -withdrawing groups, halogens, and nitrogen- and oxygen-c

185 For aldehydes with electron-withdrawing groups, significantly higher yields were ach

186 atalytic activity than those having electron-withdrawing groups.

187 phenyl rings containing electron donating or withdrawing groups.

188 ge and yields a clear dependence on electron withdrawing groups.

189 ly limited to substrates containing electron-withdrawing groups.

190 that are modulated by variation of electron withdrawing groups.

191 l ethers with electron-donating and electron-withdrawing groups.

192 c rings are modified with electron donating (withdrawing) groups, the reducing power is promoted (sup

193 e olefin by the second, inductively electron-withdrawing heteroatom is the dominant factor, and any a

194 Rats were tested for the latency to withdraw hindpaws from thermal stimuli (Hargreaves test)

195 One adult patient withdrew immediately after randomisation.

196 Among 401 randomized patients, 2 withdrew immediately after randomization, and 1 duplicat

197 the amnion and serosa - actively rupture and withdraw in late embryogenesis.

198 triazole groups are all inductively electron-withdrawing in character, with the 1,5-triazole being th

199 Life support was withdrawn in 330 of 427 patients (78%) with myoclonus an

200 at the tonic sympatho-inhibition of BDNF was withdrawn in the CHF state, thus contributing to the inc

201 Intersubject variations (n = 15; 2 subjects withdrew) in PSDs of both NA and RA samples were small (

202 years of treatment, with the limitation that withdrawn individuals were not followed up after discont

203 Cyclic voltammetry established the electron withdrawing influence of 4-BPin, which slows the rate of

204 One subject withdrew informed consent and 99 subjects (63 males) wer

205 ow conductivity, silica-based ESI probe with withdrawn inner capillary.

206 stained success, even after immunotherapy is withdrawn, is associated with the induction, expansion,

207 Three withdrew, leaving 29 intervention and 28 controls partic

208 ts that Black patients may be less likely to withdraw life-supportive measures than whites, but that

209 r willingness to endorse palliative care and withdraw life-sustaining agents in anticipation of death

210 urate and may lead to premature decisions to withdraw life-sustaining treatments (LST) in patients wh

211 Death often follows a decision to withdraw life-sustaining treatments.

212 ICU were less likely than white patients to withdraw life-sustaining treatments.

213 ed suicide and euthanasia and withholding or withdrawing life support, 3) the morality of a physician

214 e (including decisions regarding limiting or withdrawing life-prolonging interventions) and when maki

215 a potential side effect of many marketed and withdrawn medications.

216 amental substituent effect in which electron-withdrawing meta-oxazole substituents increased inhibito

217 ffective disturbances in the NSFT in ethanol withdrawn mice, and this effect was prevented by co-admi

218 tronic influencing moieties from donating to withdrawing moieties at both the heterocyclic site and t

219 The electron-withdrawing nature of the allylic leaving group facilita

220 dienes and azides, promoted by the electron-withdrawing nature of the pyridinium rings, as well as b

221 xes, resulting from the inductively electron withdrawing nature of this directing group on the Ir-C b

222 multifunctional framework of strong electron-withdrawing nature.

223 alide substituent and the number of electron-withdrawing nitro substituents.

224 demonstrate that the nature of the electron-withdrawing nitrogen protecting group has a very limited

225 One patient in the eliglustat group withdrew (non-treatment related); 39 of the 40 patients

226 es (8.5%), if excluded, would have led us to withdraw of only 21 cases (23.8%), and only 1 mutation w

227 g the sample inside the in-tube SPME device (withdraw of sample via plunger), where extraction was pe

228 ; containing types 1 and 3 poliovirus), thus withdrawing OPV2.

229 s that had used OPV in 2015 had successfully withdrawn OPV2 by ceasing use of tOPV in their national

230 ce or presence of any substitutent (electron withdrawing or electron donating) in the 3-phenyl moiety

231 predictable way in response to the electron-withdrawing or electron-donating ability of substituents

232 sition of the two external rings by electron-withdrawing or electron-donating substituents.

233 that took into account participants who had withdrawn or were lost to follow-up.

234 Six patients withdrew or had protocol violations.

235 ee did not meet inclusion criteria, chose to withdraw, or had a change in surgical management and wer

236 ant outcomes were not signed, if consent was withdrawn, or if they were a prisoner.

237 of inactivated poliomyelitis vaccine (IPV); withdraw oral poliomyelitis vaccine (OPV), starting with

238 Electron donating and electron withdrawing ortho-substituents on 2-aminobenzoic acid re

239 No patient withdrew owing to adverse events, and no adverse event w

240 Three patients withdrew owing to adverse events.

241 One woman withdrew owing to bruising at the acupoints.

242 f the donor in comparison to having electron withdrawing p-chloro (PClB) or p-cyanobenzyl ether (PCNB

243 Highly electron-withdrawing pentafluorosulfanyl groups were probed as su

244 ith catalyst 1a, featuring the most electron-withdrawing phosphine ligand.

245 ole product, is destabilized by the electron-withdrawing phthalimide substituent.

246 The enteral feeding tube was withdrawn prematurely from 48.5% of patients, and seriou

247 rbonyl substituents with increasing electron-withdrawing properties (3a, phenyl; 3b, 3,5-bis(trifluor

248 onjugated materials, but the strong electron-withdrawing properties of the required synthetic interme

249 ametrize the relative sigma- and pi-donating/withdrawing properties of the various ligands, X.

250 paper regarding both the different electron withdrawing properties of various benzyl ethers and the

251 POCOP ligand is substituted with an electron withdrawing protonated dimethylamino group at the para p

252 ate of the complex is stabilized by electron-withdrawing pyridyl ("X") substituents, but also by elec

253 Treatment of cocaine-withdrawn rats with the MAOB inhibitor deprenyl complete

254 th decisions to decline newborn screening or withdraw residual DBS.

255 showed that a short episode of VEGF exposure withdrawn shortly after the generation of durable new ve

256 was illustrated that introducing an electron-withdrawing site to amino acid anions could reduce the n

257 ings of the article and the article is being withdrawn so that a corrected manuscript can be submitte

258 nzothiazolium, which exhibit higher electron-withdrawing strength than pyridinium and quinolinium in

259 idines, further substituted with an electron-withdrawing substituent at C-5, has selectivity for subs

260 ypically require the presence of an electron-withdrawing substituent on nitrogen to suppress aerobic

261 When the aryl ring bears a remote electron-withdrawing substituent, the isomer having both the high

262 exation for arenes bearing strongly electron-withdrawing substituents (sigma > 0.43).

263 es as an example case, these highly electron-withdrawing substituents allow for polymerization of eth

264 these mechanisms can be altered by electron-withdrawing substituents and hydrogen-bonding solvents.

265 Both electron-donating and electron-withdrawing substituents are tolerated on both the boron

266 hydropyrimidines with two different electron-withdrawing substituents at the C(2) position can underg

267 Only thiosemicarbazones with electron-withdrawing substituents at the imine carbon mediated Pg

268 Only arenes with electron-withdrawing substituents can sufficiently stabilize the

269 nal energy of a 5-aryl-1,3-dioxane: electron-withdrawing substituents decrease the conformational ene

270 Compounds bearing electron-withdrawing substituents have the highest photochemical

271 Strong electron releasing or electron withdrawing substituents lead almost exclusively to a si

272 (e) Electron-withdrawing substituents lead to higher activities.

273 tuents leading to a weaker bond and electron-withdrawing substituents leading to stronger bonds, foll

274 Electron-withdrawing substituents on the aldehyde favor enol form

275 ogen, alkyl, electron-donating, and electron-withdrawing substituents on the aromatic ring.

276 iaryl urea anions correlated to the electron-withdrawing substituents on the aryl rings.

277 H3)(CF3)2)3] featuring electron-donating or -withdrawing substituents on the benzylidyne.

278 By installation of electron-withdrawing substituents on the N-aryl moieties, the the

279 Unexpectedly, electron withdrawing substituents on the salen framework resulted

280 tuned by over 70-fold by appending electron-withdrawing substituents to the phenylenediamine precurs

281 ectron-donating substituents, while electron-withdrawing substituents typically result in 1:1 binary

282 o take place despite the absence of electron-withdrawing substituents, and even with sterically encum

283 anced cell survival when growth factors were withdrawn, suggesting that these genes enhance survival

284 een the H12SubPc macrocycle and the electron-withdrawing TCBD unit directly attached at its axial pos

285 Upon withdrawing the HF diet, the reduction in oxLDL accumula

286 Motor behaviors such as walking or withdrawing the limb from a painful stimulus rely upon i

287 Upon withdrawing the suspect drug, ALT generally decrease by

288 The authors have requested to withdraw this manuscript from publication because the st

289 to continue their same dose of omalizumab or withdraw to placebo and were then followed every 4 weeks

290 Two (20%) of ten patients who were withdrawn to placebo remained entrained compared with ni

291 countries using OPV as of 2016 successfully withdrew tOPV during the globally synchronized switch fr

292 t cavity due to the presence of the electron-withdrawing transition metals, thus allowing encapsulati

293 sex had an effect on the odds of dogs being withdrawn under the different reasons.

294 g a high planarity, introduction of electron-withdrawing units for lowering the bandgap (Eg), donor-a

295 on-donor units combined with strong electron-withdrawing units possess excellent electronic and optic

296 ted hemorrhagic shock, the mean blood volume withdrawn was significantly lower in the angiotensin-con

297 as measured during or after intervention was withdrawn) was an effect modifier for both adherence to

298 The scanner table was then withdrawn while the patient remained on the table, and t

299 ll studies describing order of interventions withdrawn, with vasoactive drugs withdrawn first followe

300 ribed for the underlying kidney disease, was withdrawn within 2 months posttransplant, and no de novo